PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 53.900
- -2.070-3.70%
Close Feb 14 16:00 ET
- 53.790
- -0.110-0.20%
Post 20:01 ET
109.38BMarket Cap-12.22P/E (TTM)
56.025High53.660Low13.23MVolume56.025Open55.970Pre Close719.90MTurnover0.65%Turnover RatioLossP/E (Static)2.03BShares61.10052wk High6.70P/B109.17BFloat Cap38.18252wk Low2.42Dividend TTM2.03BShs Float74.028Historical High4.49%Div YieldTTM4.23%Amplitude8.199Historical Low54.425Avg Price1Lot Size
About Bristol-Myers Squibb Company
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Company Profile
SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher S. Boerner, PhD
- Chairman of the Board and Chief Executive Officer
- 8.46M
- Adam Lenkowsky
- Executive Vice President and Chief Commercialization Officer
- --
- David V. Elkins
- Executive Vice President and Chief Financial Officer
- 7.17M
- Dr. Samit Hirawat, M.D.
- Executive Vice President, Chief Medical Officer and Head of Development
- 6.23M
- Dr. Robert M. Plenge, M.D.,PhD
- Executive Vice President, Chief Research Officer and Head of Research
- --
- Amanda Ahn Poole
- Executive Vice President and Chief People Officer
- --
- Gregory Scott Meyers
- Executive Vice President, Chief Digital Officer and Chief Technology Officer
- --
- Phil Holzer
- Senior Vice President, Principal Accounting Officer and Controller
- --
- Sandra Leung
- Executive Vice President and General Counsel
- 5.92M
- Cari Gallman
- Executive Vice President, Corporate Affairs
- --
- Karin Shanahan
- Executive Vice President, Global Product Development and Supply
- --
- Benjamin J. Hickey, M.B.A.
- President, RayzeBio Organization
- --
- Lynelle Hoch
- President, Cell Therapy Organization
- --
- Dr. Manuel Hidalgo Medina, M.D.,PhD
- Independent Director
- 335.00K
- Paula A. Price
- Independent Director
- 365.00K
- Dr. Karen H. Vousden, PhD
- Independent Director
- 344.74K
- Phyllis R. Yale
- Independent Director
- 365.00K
- Derica W. Rice
- Independent Director
- 375.00K
- Dr. Deepak L. Bhatt, M.D.,M.P.H.
- Independent Director
- 329.97K
- Theodore R. Samuels
- Lead Independent Director
- 425.00K
- Peter J. Arduini
- Independent Director
- 359.68K
- Michael R. McMullen
- Independent Director
- --
- Dr. Julia A. Haller, M.D.
- Independent Director
- 371.68K
Trending Stocks
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?